Whanganui, New Zealand, August 31st, 2021 - TURNER New Zealand Ltd., a global health and nutritional products company that owns and operates manufacturing plants in New Zealand and marketing companies in the USA, Europe, and China, announced today the results of research that it had undertaken in New Zealand on its premium grade honey called Manuka Honey UAF1000+.

According to TURNER New Zealand founder and CEO, Noel Turner, a pioneer, and legend of the New Zealand green-lipped mussel industry dating back to the early 1970’s, the results are phenomenal, and we have already seen an uplift in demand. Turner became a prominent figure in the development and export of New Zealand grown and produced dietary supplements and functional foods in the late 1990’s and has been building export markets in the United States, Europe, and China ever since. For the past 37 years, Turner, who grew up in Whanganui NZ, spends much of his time travelling between New Zealand, Europe, United States, and China building the businesses.

TURNER has contracts in place with its beekeepers who have been in the bee-keeping business for over 100 years. This allows TURNER full traceability and quality-control over the honey they produce. Turner said, "traceability and premium quality is essential. We not only track the individual hives that our honey comes from, but we also track the geolocation of native bush where our hives are established, to ensure the best foraging of Manuka flowers for our bees".

The research team engaged by Mr. Turner had two projects to investigate. First, they examined Noel Turner’s seven sacred antioxidant superfood ingredient blend called UAF1000+, a unique and propriety blend of antioxidant Bioactives from seven New Zealand plants and minerals on live human cells. This blend was specifically created to increase the antioxidant capacity and modulate the body's inflammatory response and has been used and consumer-tested by Noel Turner for over 14 years. Secondly, Noel Turner then had the scientists add the UAF1000+ to raw manuka honey to look for any synergistic effect between the honey and the UAF1000+.

What makes UAF1000+ Unique?

The reason why only New Zealand grown plants, botanicals, and minerals are used in the production of UAF1000+ is because of the research that has been conducted over the past 30 years. The data proves that New Zealand grown plants produce far higher levels of phytochemicals and metabolites (biologically active and beneficial compounds) than the same plants and species grown in other regions of the world.

This is due to having a hole in the protective ozone layer above New Zealand, where high levels of ultra-violet (UV) light radiate from the sun and surge unfiltered on our land and into our oceans. This highly energised light turbocharges and potentially damages millions upon millions of antioxidant-rich plant-life material and humans every day.

We now understand that all plant and marine life exposed to UV in New Zealand activate survival bio-chemicals within to respond to the heightened exposure of UV-B by increasing the production of protective phytochemicals and metabolites within their cells. These compounds act as the plant's natural sunscreen and protection mechanism, and the process forms a vital part of the plant's stress response to UV-B which in turn produces significant increase of antioxidants, phytochemicals, phenolic acids, adaptogens, quercetin, flavonoids, anthocyanins, and metabolites which are highly beneficial to plant and human protection, survival, and wellbeing. It works in a way to protect the plant from further UV exposure as well as repairing the damage that has already occurred from elevated UV-B exposure.

What the Research Showed
The research scientists found that when the plant and mineral extracts were combined in a specific way, the proprietary blend called UAF1000+ (Ultimate Antioxidant Factor 1000+) was able to block almost the entire inflammatory response, as measured by the production of the inflammatory marker called interleukin-1b (IL-1b).

Once this initial benchmark was established, the UAF1000+ was then added to manuka honey to again measure the reduction in the inflammatory response. The result was a staggering 39% reduction in inflammatory response with the UAF1000+ infused manuka honey (called TURNER Manuka Honey UAF1000+) when compared to standard manuka honey that contained no UAF1000+.

The Wellington-based research scientists have confirmed that these results set a new standard of bioactivity for New Zealand produced Manuka Honey. While the health benefits of standard New Zealand manuka honey have been well publicised over the years, this is the first time that blended Manuka honey has been tested and proven to be effective in this way. Regarded as a breakthrough by the research team involved, Noel Turner will be conducting further scientific studies on his patent-pending trademark registered UAF1000+ to explore further uses of its revolutionary natural anti-inflammatory UAF1000+ formulation.

"We are committed to developing high-quality, highly-efficacious products from the vast array of New Zealand's natural ingredients, to support longevity and optimal wellbeing which are backed by solid science. It has taken me over 14 years to create UAF1000+ and I am thrilled with the scientific validation. My customers have been getting the same types of outstanding results from my products over the past 14 years that the clinical data has now validated." Turner said.

About TURNER NEW ZEALAND Ltd.

Based in California USA, with production and development facilities in New Zealand and a European sales and distribution office in Germany and China, TURNER NEW ZEALAND INC is a company that specialises in the development and commercialisation of high-quality natural products from New Zealand’s wide array of natural bioactive ingredients.